PHIA Koninklijke Philips N.V.

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort

February 12, 2026

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality imaging for clinicians.

Young patients often find MRI exams challenging, and the Snuggle™ coil was created to make the experience more comfortable and less intimidating. Its light, blanket-like design and soft, flexible structure gently wrap around the patient.

The Snuggle coil’s high-density array and flexible design allow sharp, high-resolution images and more efficient exams across a range of pediatric anatomies. These advantages can reduce the need for additional imaging or follow-up procedures while helping technologists work more efficiently through easier handling, faster setup and shorter scan times, helping to improve throughput and reduce repeat exams.

“This collaboration combines Philips MRI leadership with InkSpace Imaging’s focus on pediatric design,” said Ioannis Panagiotelis, PhD, Business Leader, MR at Philips. “The Snuggle coil shows how thoughtful design can make MRI scans less stressful for children while giving clinicians the image quality and workflow efficiency they rely on.”

Recently cleared through the U.S. Food and Drug Administration (FDA) 510(k) process, InkSpace Imaging developed the Snuggle coil to provide a more child-friendly alternative to traditional rigid devices.

“Snuggle was designed and built by InkSpace Imaging to solve a very specific pediatric challenge: comfort and performance without tradeoffs,” said Dr. Peter Fischer, CEO, InkSpace Imaging. “By enabling compatibility with Philips 3.0T MRI systems, we can bring that child-centered design to more hospitals and help care teams get the scan right the first time.”

The Snuggle pediatric coil for Philips 3.0T MR systems is now available in the United States, with rollout to additional regions planned in the future. Philips and InkSpace Imaging continue to explore opportunities to expand comfort- and efficiency-focused coil technology, supporting radiologists, technologists, and families with safer, faster, and more effective MRI exams.

For further information, please contact:

Jayme Maniatis 

Philips Global External Relations  

Tel.:   

E-mail:  

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.



Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2025 sales of EUR 18 billion and employs approximately 64,800 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
12/02/2026

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips launches IntraSight Plus to simplify coronary interventions an...

Philips launches IntraSight Plus to simplify coronary interventions and advance precision care March 25, 2026 Intuitive interventional cardiology platform combines the most comprehensive set of diagnostic and treatment planning tools to help support confident decisions and improved patient careWith FDA clearance and CE marking, IntraSight Plus streamlines the workflow efficiency of minimally invasive coronary procedures and can enable system operation time savings up to 47% in both the USA and Europe Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technolog...

 PRESS RELEASE

Philips remains No. 1 in Medtech at European Patent Office and the lar...

Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant March 24, 2026 Philips ranks No. 1 among medical technology companies in the European Patent Office Technology Dashboard 2025, filing 1,289 patent applications with the EPO in 2025.Philips’ platform-based solutions integrate hardware, software, data and AI to address clinical, operational and everyday health challenges.Philips’ innovation improved the lives of 2 billion people in 2025, with the goal of improving 2.5 billion lives per year by 2030, including 400 million people in medically unde...

 PRESS RELEASE

Philips convenes the Annual General Meeting of Shareholders 2026

Philips convenes the Annual General Meeting of Shareholders 2026 March 23, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has convened the Annual General Meeting of Shareholders (AGM) 2026 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposal to appoint John DeFord (American, 1962) as new member of the Supervisory Board, with effect from May 8, 2026.Proposals to re-appoint Paul Stoffels (Belgian, 1962), Herna Verhagen (Dutch, 1966) and Sanjay Poonen (American, 1969) as m...

 PRESS RELEASE

Philips proposes new appointment and re-appointments to its Supervisor...

Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment March 23, 2026 John DeFord proposed as new member of the Supervisory Board.Paul Stoffels, Herna Verhagen and Sanjay Poonen proposed for re-appointment as members of the Supervisory Board.Marc Harrison will step down from Philips’ Supervisory Board after his second term.Roy Jakobs proposed for re-appointment as President/CEO and Chairman and member of the Board of Management, as previously announced. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology,...

 PRESS RELEASE

Philips expands digital pathology portfolio with cloud-enabled Philips...

Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch